Correlation Between Akero Therapeutics and 4D Molecular
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and 4D Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and 4D Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and 4D Molecular Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and 4D Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of 4D Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and 4D Molecular.
Diversification Opportunities for Akero Therapeutics and 4D Molecular
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Akero and FDMT is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and 4D Molecular Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4D Molecular Therapeutics and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with 4D Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4D Molecular Therapeutics has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and 4D Molecular go up and down completely randomly.
Pair Corralation between Akero Therapeutics and 4D Molecular
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 3.84 times more return on investment than 4D Molecular. However, Akero Therapeutics is 3.84 times more volatile than 4D Molecular Therapeutics. It trades about 0.24 of its potential returns per unit of risk. 4D Molecular Therapeutics is currently generating about 0.12 per unit of risk. If you would invest 2,616 in Akero Therapeutics on November 9, 2024 and sell it today you would earn a total of 2,879 from holding Akero Therapeutics or generate 110.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. 4D Molecular Therapeutics
Performance |
| Timeline |
| Akero Therapeutics |
| 4D Molecular Therapeutics |
Akero Therapeutics and 4D Molecular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and 4D Molecular
The main advantage of trading using opposite Akero Therapeutics and 4D Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, 4D Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4D Molecular will offset losses from the drop in 4D Molecular's long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |